Thoracic Oncology
-
Text-message program may aid smoking cessation in patients with TB
A recent trial highlights the impact of a mobile health-based initiative to aid in smoking cessation within TB treatment programs, said author Maham Zahid, PhD.
-
Lung cancer survivorship: Life beyond diagnosis, treatment, and rechecks
It is no longer enough to “survive” lung cancer; our responsibility as pulmonologists is to help survivors persevere beyond it.
-
New fund empowers CHEST Networks to pursue their most impactful ideas
The Networks Advancement Fund offers financial support for projects that directly advance CHEST’s philanthropic pillars while furthering the mission of an individual Network.
-
Definitions matter: How should we define diagnostic yield in bronchoscopy?
A recent consensus statement from CHEST and the American Thoracic Society proposes a strict diagnostic yield definition, reiterating the need for close follow-up in patients with nonspecific benign findings.
-
AI-enabled approaches poised to transform diagnosis, management of lung diseases
Experts explore how AI-based tools can be used to bridge diagnostic challenges and address unmet needs in chronic respiratory disease care.
-
Establishing an outpatient pleural disease clinic
A thoracentesis clinic that offers direct, same-day outpatient care for pleural effusions enables nurse practitioners to perform both diagnostic and therapeutic procedures, speed up treatment, and quickly relieve patient symptoms.
-
AI tools like Sybil poised to improve lung cancer screening, risk prediction
The Sybil model has shown promising results in predicting lung cancer risk in diverse populations from a single CT scan, which could address gaps and disparities in current screening guidelines.
-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
-
Early data suggest air pollution may initiate lung cancer
Researcher Peiyao Wang said early results show that fine particulate matter is causing permanent DNA damage, which could have implications for lung cancer screening.
-
Making it stick: Rapid pleurodesis for MPE offers faster freedom from IPCs
Rapid pleurodesis combines prompt symptom control with the potential for pleural symphysis in a shorter time frame, allowing for potential lifestyle benefits while minimizing the risk of IPC-related complications.
-
Imaging panel discusses pace, direction of practical AI applications
Amit Gupta, MD, MRMD, CIIP, spoke about the growing application of AI imagery in early-stage lung cancer detection.
-
Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib
Experts said the results of the COMPEL trial support continued treatment with osimertinib beyond progression in this patient population.
